AVAI

Atlas Venture Associates IX Portfolio holdings

AUM $11.8M
This Quarter Return
-5.96%
1 Year Return
-58.35%
3 Year Return
-89.8%
5 Year Return
-87.69%
10 Year Return
AUM
$93.5M
AUM Growth
+$93.5M
Cap. Flow
+$0
Cap. Flow %
0%
Top 10 Hldgs %
100%
Holding
7
New
Increased
Reduced
Closed

Top Buys

No buys this quarter

Top Sells

No sells this quarter

Sector Composition

1 Healthcare 94.46%
2 Technology 3.24%
3 Communication Services 2.3%
Name Market Value Portfolio Weight Shares or Principal Shares
Change %
Capital Flow
NTLA icon
1
Intellia Therapeutics
NTLA
$1.22B
$26.4M 28.28% 1,615,321
SYBX icon
2
Synlogic
SYBX
$17M
$24.1M 25.81% 2,651,963
SPRO icon
3
Spero Therapeutics
SPRO
$116M
$15.8M 16.95% 1,376,968
SURF
4
DELISTED
Surface Oncology, Inc. Common Stock
SURF
$13.1M 14.01% 4,645,453
COGT icon
5
Cogent Biosciences
COGT
$1.69B
$8.81M 9.42% 3,361,535
CBLK
6
DELISTED
Carbon Black, Inc. Common Stock
CBLK
$3.03M 3.24% 181,273
SNAP icon
7
Snap
SNAP
$12.1B
$2.15M 2.3% 150,160